GLSI

Greenwich Lifesciences INC

+$13.3M

Net Activity

Institutions Holding

64

Popularity Rank

#5421

Avg Weight

0.00%

Total Value

$41.1M

Ownership Trend

64 institutions currently hold GLSI, with 38 net buyers and 22 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

22

Net Buying Institutions

38

Key Holders

View all 64 holding institutions

Quarterly Activity

Recent Activity

+$30.1M

Total Buy Value

$5.3M

Total Sell Value

New buy20
Trim13
Add18
Sold out9

38

Net Buyers

22

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding GREENWICH LIFESCIENCES INC (GLSI)?
Major stakeholders currently include BlackRock, Inc. ($10.4M), Vanguard Capital Management LLC ($7.2M), Geode Capital Management, LLC ($3.7M). Based on the latest 13F filings, there are a total of 64 tracked investment funds and institutions maintaining positions in GLSI.
What is the overall institutional sentiment toward GLSI recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $13.3M, driven by 38 managers accumulating shares while 22 reduced their exposure.
Which institutions have been selling or reducing their GLSI positions?
In the latest period, 13 funds trimmed their holdings, and 9 managers completely exited their positions. The aggregate reported sell value was $5.3M.
Are there any notable investors adding GLSI to their portfolios?
Yes, buying activity remains notable. 20 institutions opened new positions in {ticker}, and 18 existing holders added to their shares. The total reported buy value for the quarter amounted to $30.1M.

Related Stocks